Study of Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient
STIMOBIII
Study of Multi-site Neuromuscular Electrical Stimulation to Increase Spontaneous Physical Activity in Obesity Patient Carrying Severe Inactive: Randomized Controlled Trial vs Placebo
1 other identifier
interventional
73
1 country
3
Brief Summary
The study was designed to test the following hypotheses: Main Objective: To compare the level of spontaneous physical activity at 3 months after re-entrainment by multi-site electrical stimulation (m-ES), measured by actigraphy over 7 days, compared to conventional care (lifestyle and dietary advice and placebo (simulated) electrostimulation) (control arm). Secondary Objectives: To compare the metabolic, inflammatory, cardiovascular and functional parameters, physical activity, quality of life and quality of sleep, at 3 months and at 2 years in the two groups. Design: We will conduct a multicenter controlled study vs. reference care with randomization into two parallel groups and double-blind (placebo electrostimulation). Patients will have the ES material available at home and will be supervised by monthly visits over 3 months and by telephone follow-up for two years. The study size calculation is based on physical activity, the percentage of lean body mass and arterial stiffness measured in the OBEX study (NCT01155271). This project will determine whether the training strategy is effective for increasing physical activity and/or in inducing significant metabolic and cardiovascular effects in these patients after 2 years. In addition, it provides a solid base of investigation for the study of the interactions between muscle contraction and cardio-metabolic health with greater precision.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Apr 2014
Longer than P75 for not_applicable obesity
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 9, 2014
CompletedFirst Submitted
Initial submission to the registry
August 5, 2014
CompletedFirst Posted
Study publicly available on registry
August 6, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedMay 16, 2024
May 1, 2024
10.1 years
August 5, 2014
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in physical activity
* Number of steps per day * Number of MET (metabolic equivalent of task) per day
After a period of monthly supervised training program by neuromuscular electrical stimulation at home (12th wk)
Secondary Outcomes (8)
Changes in body composition
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
Change in arterial stiffness
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and during a period of spontaneous training (48 th, 72 th, 96 th week)
Change in endothelial function
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
Change in plasmatic biomarkers
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
Change in quality of life
After a period of monthly supervised training by neuromuscular electrical stimulation at home (12th wk) and after a period of spontaneous training (92th week )
- +3 more secondary outcomes
Study Arms (2)
Kneehab®
ACTIVE COMPARATOR5 sessions per week
Placebo
PLACEBO COMPARATOR5 sessions per week
Interventions
12 weeks : 5 sessions per week (1 supervised session at home every month) 92 weeks : spontaneous training (supervised by phone every month)
Eligibility Criteria
You may qualify if:
- Obese patients with BMI \> 35 kg/m²
- Continuous Positive Airway Pressure (CPAP) treatment and \> 4h observance per night to the patient with OSAS (obstructive sleep apnoea syndrome)
- Patients who give written consent
- Patients who subscribed social insurance
You may not qualify if:
- Contraindication to exercise
- Pregnant or breast-feed woman
- Patients under guardianship
- Imprisoned patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Hôpital Universitaire de Grenoble
Grenoble, 38043, France
Hôpital universitaire de Lyon
Lyon, 69310, France
Hôpital universitaire de Saint Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renaud TAMISIER, Pr
Laboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2014
First Posted
August 6, 2014
Study Start
April 9, 2014
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
May 16, 2024
Record last verified: 2024-05